About the Company
bellerophon therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BLPH News
Bellerophon Therapeutics Inc BLPH
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Bellerphon Therapeutics stock plunges toward record selloff after lung disease treatment performs worse than placebo in late-stage trial
Shares of Bellerophon Therapeutics Inc. plummeted 83% toward a record one-day decline, after the biotherapeutics company said its lung-disease treatment failed to meet its primary endpoint in a ...
Bellerophon Therapeutics Inc 0HMP
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bellerophon Therapeutics, Inc. (BLPH) stock forecast and price target
Find the latest Bellerophon Therapeutics, Inc. BLPH analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Bellerophon Therapeutics Inc (BLPH) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
5 Stocks With Recent Price Strength Amid March Rally
These companies are — Bellerophon Therapeutics Inc. BLPH, Crawford & Co. (CRD.B), Riley Exploration Permian Inc. REPX, Harrow Health Inc. HROW and Lantheus Holdings Inc. LNTH. We have primarily ...
Keith Crandell's Net Worth
Keith Crandell has an estimated net worth of $2.3 Billion. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., KYTHERA BIOPHARMACEUTICALS INC ...
PTGX Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing ...
TRDA Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its EEV platform ...
Bellerophon Therapeutics, Inc. Common Stock (BLPH)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...
Bellerophon Therapeutics, Inc. (BLPH)
*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Loading the latest forecasts...